Elevated arterial stiffness in postmenopausal women with osteoporosis.

[1]  A. Taguchi,et al.  Forearm endothelial function and bone mineral loss in postmenopausal women. , 2004, Atherosclerosis.

[2]  Ivar Heuch,et al.  Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. , 2004, American journal of epidemiology.

[3]  G. Sesti,et al.  Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. , 2004, The American journal of cardiology.

[4]  A. Yamashina,et al.  Increased pulse wave velocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia. , 2003, The Journal of clinical endocrinology and metabolism.

[5]  Y. Ikari,et al.  Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery Disease , 2002, Circulation.

[6]  K. Kawecka-Jaszcz,et al.  The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension , 2002, Journal of Human Hypertension.

[7]  Sundeep Khosla,et al.  Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.

[8]  Ego Seeman,et al.  Pathogenesis of bone fragility in women and men , 2002, The Lancet.

[9]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[10]  G. Malcom,et al.  Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. , 2002, Atherosclerosis.

[11]  M. Mendelsohn,et al.  Protective effects of estrogen on the cardiovascular system. , 1999, The American journal of cardiology.

[12]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[13]  A. Hofman,et al.  Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Hofman,et al.  Increased plasma homocysteine after menopause. , 2000, Atherosclerosis.

[15]  J. Cohn.  Vascular wall function as a risk marker for cardiovascular disease. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[16]  C. Hassager,et al.  The association between low bone mass at the menopause and cardiovascular mortality. , 1999, The American journal of medicine.

[17]  A. Bank,et al.  Smooth muscle relaxation: effects on arterial compliance, distensibility, elastic modulus, and pulse wave velocity. , 1998, Hypertension.

[18]  E. Barengolts,et al.  Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal Women , 1998, Calcified Tissue International.

[19]  J. Manson,et al.  Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. , 1997, Circulation.

[20]  E. Lehmann,et al.  Non-invasive assessment of cardiovascular disease in diabetes mellitus , 1997, The Lancet.

[21]  F. Parhami,et al.  Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[22]  V. Fuster,et al.  Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. , 1996, Circulation.

[23]  L. Melton,et al.  The worldwide problem of osteoporosis: insights afforded by epidemiology. , 1995, Bone.

[24]  B. Pannier,et al.  Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. , 1995, Hypertension.

[25]  B. Riggs,et al.  Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Weissberg,et al.  High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[27]  D. Kiel,et al.  The effect of postmenopausal estrogen therapy on bone density in elderly women. , 1993, The New England journal of medicine.

[28]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[29]  S. Globits,et al.  Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. , 1993, The American journal of medicine.

[30]  S. Cummings,et al.  Factors Associated with Appendicular Bone Mass in Older Women , 1993, Annals of Internal Medicine.

[31]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[32]  Claus Christiansen,et al.  Diagnosis of Osteoporosis , 1992, Southern medical journal.

[33]  B. Zumoff,et al.  Sex hormones and coronary disease: a review of the clinical studies , 1990, Steroids.

[34]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[35]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.